256 related articles for article (PubMed ID: 19289603)
1. Imatinib attenuates skeletal muscle dystrophy in mdx mice.
Huang P; Zhao XS; Fields M; Ransohoff RM; Zhou L
FASEB J; 2009 Aug; 23(8):2539-48. PubMed ID: 19289603
[TBL] [Abstract][Full Text] [Related]
2. Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function.
Ermolova NV; Martinez L; Vetrone SA; Jordan MC; Roos KP; Sweeney HL; Spencer MJ
Neuromuscul Disord; 2014 Jul; 24(7):583-95. PubMed ID: 24844454
[TBL] [Abstract][Full Text] [Related]
3. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice.
Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ
Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
[TBL] [Abstract][Full Text] [Related]
6. Curcumin alleviates dystrophic muscle pathology in mdx mice.
Pan Y; Chen C; Shen Y; Zhu CH; Wang G; Wang XC; Chen HQ; Zhu MS
Mol Cells; 2008 Jun; 25(4):531-7. PubMed ID: 18460899
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine treatment reduces TNF-α levels and myonecrosis in diaphragm muscle of mdx mice.
de Senzi Moraes Pinto R; Ferretti R; Moraes LH; Neto HS; Marques MJ; Minatel E
Clin Nutr; 2013 Jun; 32(3):472-5. PubMed ID: 22727548
[TBL] [Abstract][Full Text] [Related]
8. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M
Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of radiation-induced skin fibrosis with imatinib.
Horton JA; Chung EJ; Hudak KE; Sowers A; Thetford A; White AO; Mitchell JB; Citrin DE
Int J Radiat Biol; 2013 Mar; 89(3):162-70. PubMed ID: 23083077
[TBL] [Abstract][Full Text] [Related]
10. Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors.
Ito T; Ogawa R; Uezumi A; Ohtani T; Watanabe Y; Tsujikawa K; Miyagoe-Suzuki Y; Takeda S; Yamamoto H; Fukada S
Neuromuscul Disord; 2013 Apr; 23(4):349-56. PubMed ID: 23313020
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy.
Haberler C; Gelpi E; Marosi C; Rössler K; Birner P; Budka H; Hainfellner JA
J Neurooncol; 2006 Jan; 76(2):105-9. PubMed ID: 16205964
[TBL] [Abstract][Full Text] [Related]
12. Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
Bizario JC; Cerri DG; Rodrigues LC; Oliveira GL; Nomizo A; de Araujo DD; Fukuhara PS; Ribeiro JC; de Castro FA; Costa MC
J Neuroimmunol; 2009 Jul; 212(1-2):93-101. PubMed ID: 19508953
[TBL] [Abstract][Full Text] [Related]
13. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
[TBL] [Abstract][Full Text] [Related]
14. Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.
McGary EC; Onn A; Mills L; Heimberger A; Eton O; Thomas GW; Shtivelband M; Bar-Eli M
J Invest Dermatol; 2004 Feb; 122(2):400-5. PubMed ID: 15009722
[TBL] [Abstract][Full Text] [Related]
15. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Therapy With Omega-3 Ameliorates Myonecrosis and Benefits Skeletal Muscle Regeneration in Mdx Mice.
Apolinário LM; De Carvalho SC; Santo Neto H; Marques MJ
Anat Rec (Hoboken); 2015 Sep; 298(9):1589-96. PubMed ID: 26011009
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of α7 nicotinic acetylcholine receptor (nAChRα7) inhibits muscular degeneration in mdx dystrophic mice.
Leite PE; Gandía L; de Pascual R; Nanclares C; Colmena I; Santos WC; Lagrota-Candido J; Quirico-Santos T
Brain Res; 2014 Jul; 1573():27-36. PubMed ID: 24833065
[TBL] [Abstract][Full Text] [Related]
18. Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice.
Rhee CK; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim YK; Kim KH; Kim TJ; Kim JW
Respiration; 2011; 82(3):273-87. PubMed ID: 21659722
[TBL] [Abstract][Full Text] [Related]
19. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.
Daniels CE; Wilkes MC; Edens M; Kottom TJ; Murphy SJ; Limper AH; Leof EB
J Clin Invest; 2004 Nov; 114(9):1308-16. PubMed ID: 15520863
[TBL] [Abstract][Full Text] [Related]
20. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo.
Wang S; Wilkes MC; Leof EB; Hirschberg R
FASEB J; 2005 Jan; 19(1):1-11. PubMed ID: 15629889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]